Morgan Stanley Ironwood Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 4,321,589 shares of IRWD stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,321,589

Previous 4,860,828 11.09%

Holding current value

$19.9 Million

Previous $31.7 Million 43.96%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.93 - $7.04 $2.12 Million - $3.8 Million	-539,239 Reduced 11.09%	4,321,589 $17.8 Million
Q2 2024 Oct 17, 2024	BUY	$5.58 - $8.61 $12.2 Million - $18.8 Million	2,182,712 Added 81.5%	4,860,828 $31.7 Million
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $12.2 Million - $18.8 Million	2,182,712 Added 81.5%	4,860,828 $31.7 Million
Q1 2024 Oct 17, 2024	SELL	$8.32 - $15.45 $18.2 Million - $33.7 Million	-2,182,712 Reduced 44.9%	2,678,116 $23.3 Million
Q1 2024 Aug 16, 2024	BUY	$8.32 - $15.45 $4.41 Million - $8.19 Million	530,298 Added 24.69%	2,678,116 $23.3 Million
Q1 2024 May 15, 2024	BUY	$8.32 - $15.45 $4.41 Million - $8.19 Million	530,298 Added 24.69%	2,678,116 $23.3 Million
Q4 2023 Aug 16, 2024	SELL	$8.79 - $11.51 $23.8 Million - $31.2 Million	-2,713,010 Reduced 55.81%	2,147,818 $24.6 Million
Q4 2023 Feb 13, 2024	BUY	$8.79 - $11.51 $2.17 Million - $2.84 Million	247,035 Added 13.0%	2,147,818 $24.6 Million
Q3 2023 Nov 15, 2023	SELL	$8.25 - $11.35 $9.63 Million - $13.3 Million	-1,167,556 Reduced 38.05%	1,900,783 $18.3 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $7.38 Million - $8.48 Million	-730,654 Reduced 19.23%	3,068,339 $32.6 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $11.8 Million - $14.3 Million	1,140,486 Added 42.9%	3,798,993 $40 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $4.51 Million - $5.66 Million	455,105 Added 20.65%	2,658,507 $32.9 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $3.79 Million - $4.63 Million	-374,129 Reduced 14.52%	2,203,402 $22.8 Million
Q2 2022 Oct 27, 2022	BUY	$11.05 - $12.72 $3.25 Million - $3.74 Million	293,707 Added 12.86%	2,577,531 $29.7 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $3.25 Million - $3.74 Million	293,707 Added 12.86%	2,577,531 $29.7 Million
Q1 2022 Oct 27, 2022	SELL	$10.61 - $12.88 $3.12 Million - $3.78 Million	-293,707 Reduced 11.39%	2,283,824 $28.7 Million
Q1 2022 May 13, 2022	BUY	$10.61 - $12.88 $13.1 Million - $15.8 Million	1,230,402 Added 116.8%	2,283,824 $28.7 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $7.11 Million - $9.13 Million	-654,367 Reduced 38.32%	1,053,422 $12.3 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $20.4 Million - $23.8 Million	1,707,789 New	1,707,789 $22.3 Million

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $706M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account